The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 trial of autologous dendritic cell vaccination with imiquimod immunomodulation in children and adults with refractory sarcoma.
 
Aditi Dhir
No Relationships to Disclose
 
Tulay Koru-Sengul
No Relationships to Disclose
 
James Grosso
No Relationships to Disclose
 
Gina Z. D'Amato
Consulting or Advisory Role - Blueprint Medicines; Deciphera; Epizyme
Speakers' Bureau - Janssen Oncology; Lilly
 
Matteo M. Trucco
No Relationships to Disclose
 
Andrew Rosenberg
No Relationships to Disclose
 
Eli Gilboa
No Relationships to Disclose
 
John M. Goldberg
Employment - Oncorus
Leadership - Oncorus
Stock and Other Ownership Interests - Oncorus
 
Jonathan C. Trent
Consulting or Advisory Role - Agios; Bayer; Blueprint Medicines; C4 Therapeutics; Daiichi Sankyo; Deciphera; Epizyme; Janssen; Lilly; Novartis
 
Breelyn A. Wilky
Honoraria - GlaxoSmithKline
Consulting or Advisory Role - Adaptimmune; Daiichi Sankyo; Deciphera; SpringWorks Therapeutics
Research Funding - Agenus
Travel, Accommodations, Expenses - Adaptimmune; Daiichi Sankyo; Deciphera